Clinical Trial Update: Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin, capecitabine, and bevacizumab for metastatic esophagogastric adenocarcinoma has completed enrollment with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Duke University | Conditions: Esophageal Neoplasms, Stomach Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2015-01-28